focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 101.00
Bid: 99.00
Ask: 103.00
Change: 1.00 (1.00%)
Spread: 4.00 (4.04%)
Open: 100.00
High: 101.00
Low: 100.00
Prev. Close: 100.00
CNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Supply Agreement

13 Jul 2022 07:00

RNS Number : 2508S
Concurrent Technologies PLC
13 July 2022
 

 

This announcement contains inside information

 

13 July 2022

Concurrent Technologies Plc

("Concurrent Technologies" or the 'Company')

Supply Agreement with Global Medical Technology Company

 

Concurrent Technologies, a world leading specialist in the design and manufacture of high-end embedded computer boards for critical applications, has entered into a supply agreement with a Fortune 500 global medical technology company, and has received an initial USD$2.2 million order for first year product shipments. Initial shipments have already commenced for qualification purposes with volume shipments scheduled to start at the end of 2022. The customer is then expected to place similar size orders on an annual basis for several years to come.

The customer's needs were multi-faceted and challenging. Concurrent Technologies developed a product that maintained backwards compatibility with the external interfaces of the prior product; demonstrated the ability to manage and overcome issues that would prevent multi-year production without changes; and met all the customer's quality and supply chain requirements. Concurrent Technologies also ported the customer's application software to work seamlessly on the new hardware, accelerating the introduction of the customer's next generation machine.

Dr. Miles Adcock, CEO of Concurrent Technologies, commented: "We pride ourselves on delivering extremely reliable products to a very high-quality standard which suits customers from many vertical market segments including medical. The required product was developed at pace in line with the expectation we have set for increasing the cadence of new product introductions. With the customer intending to place similar size orders on an annual basis for several years to come, this is expected to provide a steady revenue stream that is wholly accretive to our current business."

 

Enquiries:

Concurrent Technologies Plc

Miles Adcock, CEO +44 (0)1206 752626

 

SEC Newgate (Financial PR)

Bob Huxford +44 (0)20 3757 6880

Isabelle Smurfit +44 (0)20 3757 6880

Group email concurrent@secnewgate.co.uk

 

Cenkos Securities Plc (NOMAD)

Neil McDonald +44 (0)131 220 9771

Peter Lynch +44 (0)131 220 9772

 

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high-performance, long-life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest 9th generation embedded Intel® Core™ processors, Intel® Xeon® and Intel® Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.

For more information on Concurrent Technologies Plc and its products please visit www.gocct.com.

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRSFSEEEEESEDW
Date   Source Headline
20th May 20094:35 pmRNSDistribution of Annual Report & Accounts
20th May 20093:09 pmRNSHolding(s) in Company (Replacement)
20th May 20092:44 pmRNSHolding(s) in Company
18th May 20094:10 pmRNSHolding(s) in Company
5th May 20094:11 pmRNSHolding(s) in Company
27th Apr 20097:00 amPRNFinal Results
20th Apr 20092:13 pmRNSNotice of Results
16th Apr 20094:57 pmRNSHolding(s) in Company
2nd Apr 20097:00 amPRNProduct Launch
9th Mar 20092:32 pmRNSTotal Voting Rights
4th Feb 20097:00 amRNSTransaction in Own Shares
6th Jan 200912:12 pmPRNTrading Statement
5th Dec 20084:02 pmPRNProduct Launch
4th Dec 20084:00 pmPRNDirector/PDMR Shareholding
28th Nov 200810:51 amRNSTotal Voting Rights
21st Nov 20088:00 amRNSTransaction in Own Shares
10th Nov 200810:26 amPRNProduct Launch
7th Nov 20082:46 pmRNSTransaction in Own Shares
4th Nov 20088:00 amRNSTransaction in Own Shares
31st Oct 200812:05 pmRNSTotal Voting Rights
24th Oct 20087:00 amRNSTreasury Shares
22nd Oct 20087:00 amRNSTreasury Shares
21st Oct 20083:14 pmRNSDirector/PDMR Shareholding
21st Oct 200812:27 pmRNSDirector/PDMR Shareholding
17th Oct 20081:43 pmRNSTreasury Shares
10th Oct 20081:16 pmRNSTransaction in Own Shares
2nd Oct 20083:50 pmPRNDistribution of Half-yearly Report
30th Sep 20083:58 pmRNSTotal Voting Rights
26th Sep 20084:06 pmPRNProduct Launch
4th Sep 20087:00 amPRNHalf-yearly Report
1st Sep 20084:17 pmPRNNotice of Results
14th Aug 20084:00 pmPRNProduct Launch
31st Jul 200812:34 pmRNSTotal Voting Rights
15th Jul 20088:01 amPRNProduct Launch
10th Jul 20081:09 pmPRNTrading Statement
30th Jun 20083:22 pmRNSTransaction in Own Shares
27th Jun 20084:14 pmRNSTransaction in Own Shares
26th Jun 20084:03 pmPRNSenior Management Appointments
22nd May 20084:18 pmPRNAGM Statement
8th May 20085:54 pmRNSHolding(s) in Company
7th May 20087:00 amPRNProduct Launch
15th Apr 20081:18 pmRNSDirector/PDMR Shareholding
11th Apr 20085:15 pmRNSDirector/PDMR Shareholding
8th Apr 20087:01 amRNSDirector/PDMR Shareholding
26th Mar 20084:25 pmRNSDirector/PDMR Shareholding
26th Mar 20087:00 amPRNFinal Results
19th Mar 20084:23 pmPRNNotice of Results
28th Feb 20081:06 pmPRNProduct Development
22nd Feb 20082:40 pmPRNProduct Launch
31st Dec 200710:01 amRNSRetirement of Non Exec Dir

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.